Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Osimertinib 80, Non-Small Cell Lung Cancer, neoadjuvant

Protocol-ID: 2943 V1.0 (Mini), OSIM80, NSCLC, neoadj.

Indication(s)

  • Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
    EGFR exon 19 deletion mutation ● EGFR exon 21 Leu858Arg mutation
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 22.07.2025